Ella Therapeutics
Microbiome-based Products for Combination Therapy with Immuno-oncology
Health Tech & Life Sciences
Non Active, Jul 2022 ceased to operate
Company Overview
Snapshot
Founded in May 2019 by Yaron Lemelbaum and Gal Markel, Ella Therapeutics operated with 1–10 employees. The company's primary focus was on developing microbiome-derived therapies.
Business overview
Ella Therapeutics is a Health Tech & Life Sciences company focused on developing microbiome-based products for combination therapy with immuno-oncology. The company's core technology aims to overcome immunotherapy resistance in cancer patients by altering the gut microbiome through engineered bacteria or a live biotherapeutic product. Ella Therapeutics' platform is designed for various major cancer indications, serving the pharmaceutical and life sciences sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is Ella Therapeutics' primary mission?
- Ella Therapeutics' mission is to overcome immunotherapy resistance in cancer patients by altering the gut microbiome through engineered bacteria or a live biotherapeutic product.
- When was Ella Therapeutics founded?
- Ella Therapeutics was founded in May 2019.
- Who are the co-founders of Ella Therapeutics?
- Yaron Lemelbaum and Gal Markel are the co-founders of Ella Therapeutics.
- What is the primary sector of Ella Therapeutics?
- Ella Therapeutics operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- What is the current status of Ella Therapeutics?
- Ella Therapeutics is currently non-active, having ceased operations in July 2022.